You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

mass. movers

Vertex Pharmaceuticals to join S&P 500

Jeffrey Leiden is Vertex’s CEO and president.

Essdras M Suarez/Globe Staff

Jeffrey Leiden is Vertex’s CEO and president.

Continue reading below

Vertex Pharmaceuticals is one of two companies that will join the S&P 500, along with Ametek Inc., a Pennsylvania electronic instruments firm. The pair will switch spots with AMD Inc. and SAIC Inc., which will join the MidCap 400. S&P said the moves will better align the businesses with indices more representative of their market capitalizations. Both Vertex and Ametek have market caps of more than $10 billion, the S&P said. The switch will take place after trading closes Sept. 20.

Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.